# Revolution Medicines turned the most notorious undruggable target in oncology into a whole drug class

- slug: revolution-medicines-turned-the-most-notorious-undruggable-target-in-oncology-into-a-whole-drug
- date: 2026-04-15
- category: Biotech & Life Sciences

Daraxonrasib turned RAS from oncology's most notorious punchline into a $2B pipeline bet. The survival benefit is real. The question is whether it's a platform or a one-drug story.

---